Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 95
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Biol Regul Homeost Agents ; 31(1): 239-244, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28337899

RESUMEN

The aim of this study was to evaluate substance P (SP) levels and the effect of a non-steroidal anti-inflammatory drug (NSAID), ketoprofen, on SP in the pericoronal gingival tissue after extraction of upper third molars. A sample of 20 young non-smoking systemically healthy adults of both sexes, with a healthy upper third molar to extract for orthodontic purposes, was selected. After extraction, a sample of the gingival tissue of the pericoronal region was collected with a sterile scalpel, placed into test tubes and kept frozen at -20°C until the SP determination. SP levels were determined by using a commercially available enzyme immunoassay (ELISA) kit. The subjects were randomly divided into two groups: group 1 received a single dose of ketoprofen 30 minutes prior to the experimental procedure. The subjects of group 2 did not receive any kind of drug administration before extraction. The patients were asked to complete a diary on the postoperative pain. A relevant amount of SP was measured in all the gingival samples. No statistically significant difference could be detected in SP expression between the two groups. In group 1 pain appearance was significantly delayed (6.2±0.13 hours) in comparison with group 2 (3.95±0.2 hours). In this small selected group of subjects and limited study design, preventive administration of ketoprofen did not significantly affect the gingival levels of SP, the clinical recommendation emerging is that of NSAID administration postoperatively but before pain appearance in order to optimize the management of pain of the patient.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Cetoprofeno/uso terapéutico , Tercer Molar/cirugía , Dimensión del Dolor/métodos , Dolor Postoperatorio/prevención & control , Sustancia P/genética , Adulto , Ensayo de Inmunoadsorción Enzimática , Femenino , Expresión Génica , Encía/efectos de los fármacos , Encía/inervación , Encía/cirugía , Humanos , Masculino , Dolor Postoperatorio/fisiopatología , Sustancia P/metabolismo , Extracción Dental
2.
Eur J Paediatr Dent ; 15(1): 51-4, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24745593

RESUMEN

AIM: Evaluate the correlations between unstimulated salivary flow, pH and level of S. mutans, analysed through real time PCR, in caries-free and caries-active children. MATERIALS AND METHODS: Thirty healthy children were divided into 2 groups: test group (DMFT/dmft ≥ 3 and at least 1 active caries lesion) and control group (DMFT/dmft=0). Un-stimulated saliva was collected, pH was measured and S. mutans and total bacterial amount were evaluated with real-time PCR analysis. RESULTS: Unstimulated salivary flow in the test group was significantly lower (p = 0.0269) compared to group control. The level of S. mutans was higher in the test group (p = 0.176), and an inverse correlation was recorded between total bacterial amount and un-stimulated salivary flow (p = 0.063). In the control group a positive relationship was found between total bacterial amount and S. mutans (p = 0.045) and an inverse correlation between pH and S. mutans (p = 0.088). A t-test and a linear regression analysis were performed. CONCLUSION: A higher salivary flow and an increased salivary pH seem to represent protective factors against caries in children, while high levels of S. mutans are correlated with caries active lesions. Caries risk assessment should be performed considering all parameters involved in the development of the disease.


Asunto(s)
Caries Dental/metabolismo , Saliva/metabolismo , Streptococcus mutans/aislamiento & purificación , Adolescente , Carga Bacteriana , Niño , Índice CPO , ADN Bacteriano/análisis , Caries Dental/microbiología , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Reacción en Cadena en Tiempo Real de la Polimerasa , Medición de Riesgo , Saliva/microbiología , Saliva/fisiología , Tasa de Secreción/fisiología
3.
J Clin Dent ; 25(4): 71-5, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-26054182

RESUMEN

OBJECTIVE: This study evaluated whether sodium bicarbonate applied on the oral mucosa through a new mucoadhesive spray (Cariex) could control a drop in salivary pH after a glucose rinse, and therefore enhance the buffering potential of saliva. METHODS: A sample of 50 healthy adults was selected. At day 1, the measurement of salivary pH was performed in the lower fornix in correspondence with the lower molars. Each subject rinsed with 10 ml of a 10% glucose solution and then pH was monitored continually for 40 minutes. At day 2, the same experimental procedure was repeated and three shots of the spray were administered on the oral mucosa. The tested spray is composed of sodium bicarbonate, xylitol, and excipients. RESULTS: Without the mucoadhesive spray, salivary pH became significantly lower following the glucose rinse (p < 0.01). Following the spray, the time in which the pH remained lower than 6.0 was reduced statistically significantly (p < 0.01). A continual rise of salivary pH was observed for the 40 minutes in which the pH recording was performed. Conclusions: The use of a sodium bicarbonate spray on the mucosa was shown to control the lowering of salivary pH following carbohydrate consumption, and might therefore add to the prevention of caries and dental erosion.


Asunto(s)
Cariostáticos/uso terapéutico , Glucosa/administración & dosificación , Saliva/química , Bicarbonato de Sodio/uso terapéutico , Xilitol/uso terapéutico , Administración Oral , Adulto , Aerosoles , Cariostáticos/administración & dosificación , Femenino , Voluntarios Sanos , Humanos , Concentración de Iones de Hidrógeno , Italia , Masculino , Bicarbonato de Sodio/administración & dosificación , Xilitol/administración & dosificación
4.
Eur J Paediatr Dent ; 13(4): 293-6, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23270286

RESUMEN

AIM: This study was performed to evaluate the effect of a glucose rinse and of plaque accumulation on pH of tooth surface in healthy adolescents with a device used in gastroenterology and never tested in the oral cavity. MATERIALS AND METHODS: Values of pH were monitored in 12 adolescents using a portable device (pH-day 2® Menfis, bioMedica S.r.l., Bologna, Italy) with a disposable antimonium electrode kept in contact with the interproximal surface of the upper molars for 40 minutes respectively before and after a one-minute rinse with 10 ml of a 10% glucose solution. The same procedure was repeated in the same subjects after 72 hours of plaque accumulation. RESULTS: The device tested resulted difficult to use on the tooth surface because of the size of the active part of the probe. The glucose rinse caused a statistically significant decrease of the mean pH, restrained in basal conditions (d = -0.16, p <0.05), clinically relevant after plaque accumulation (d = -1.24, p <0.05). Time in minutes of pH < 6 grew considerably only in case of combination of plaque accumulation and glucose rinse (d = 20.90, p <0.05). A Stephan's curve of drop and recover of the pH values was not recorded. CONCLUSIONS: The continuous recording of pH of natural plaque present on the tooth could represent an alternative to other techniques found in literature. More studies are necessary to verify the suitability of this new device for the monitoring of pH in the oral cavity.


Asunto(s)
Placa Dental/metabolismo , Glucosa/metabolismo , Diente Molar/metabolismo , Adolescente , Antimonio , Cariogénicos/metabolismo , Electrodos , Diseño de Equipo , Monitorización del pH Esofágico/instrumentación , Estudios de Seguimiento , Humanos , Concentración de Iones de Hidrógeno , Edulcorantes/metabolismo , Factores de Tiempo
5.
Bratisl Lek Listy ; 111(8): 443-8, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21033624

RESUMEN

Advances researches in the diagnosis and treatment of childhood, adolescent and adult cancer have greatly increased the life expectancy of premenopausal women with cancer. However, one of the serious side effects of these treatments is the risk of damage to fertility. The ovaries are very sensitive to cytotoxic and radiotherapeutic treatment. The only established method of fertility preservation is embryo cryopreservation according to the Ethics Committee of the American Society for Reproductive Medicine (2005), but this option requires the patient to be of pubertal age, have a partner or use donor sperm, and be able to undergo a cycle of ovarian stimulation, which is not possible when the radiotherapy has to be initiated immediately or when stimulation is contraindicated according to the type of cancer. For patients who need immediate radiotherapy, cryopreservation of ovarian tissue is the only possible alternative. This manuscript reports the different techniques of cryopreservation and the results of transplantation of cryopreserved ovarian tissue. The current techniques allow cryopreservation of human ovarian fragments for a long time with good follicular survival rate after thawing. Numerous studies ultimately in this field have demonstrated to improve the survival rate of the oocytes and cryopreserved follicles. Moreover this manuscript includes a case of a 17-year-old girl who had to undergo pelvic irradiation for non-Hodgkin's lymphoma and the laparoscopic treatment to preserve the fertility (Fig. 2, Ref. 47).


Asunto(s)
Criopreservación , Ovario , Adolescente , Criopreservación/métodos , Femenino , Fertilidad/efectos de la radiación , Humanos , Neoplasias/radioterapia , Ovario/efectos de la radiación , Ovario/trasplante , Pelvis/efectos de la radiación , Recolección de Tejidos y Órganos/métodos
6.
Phys Rev E Stat Nonlin Soft Matter Phys ; 77(3 Pt 2): 036703, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18517553

RESUMEN

The gas dynamics of a stationary hot-gas jet supersonically expanding into a low pressure environment is studied through numerical simulations. A hybrid coupled continuum-molecular approach is used to model the flow field. Due to the low pressure and high thermodynamic gradients, continuum mechanics results are doubtful, while, because of its excessive time expenses, a full molecular method is not feasible. The results of the hybrid coupled continuum-molecular approach proposed have been successfully validated against experimental data by R. Engeln [Plasma Sources Sci. Technol. 10, 595 (2001)] obtained by means of laser induced fluorescence. Two main questions are addressed: the necessity of applying a molecular approach where rarefaction effects are present in order to correctly model the flow and the demonstration of an invasion of the supersonic part of the flow by background particles. A comparison between the hybrid method and full continuum simulations demonstrates the inadequacy of the latter, due to the influence of rarefaction effects on both velocity and temperature fields. An analysis of the particle velocity distribution in the expansion-shock region shows clear departure from thermodynamic equilibrium and confirms the invasion of the supersonic part of the flow by background particles. A study made through particles and collisions tracking in the supersonic region further proves the presence of background particles in this region and explains how they cause thermodynamic nonequilibrium by colliding and interacting with the local particles.

7.
Acta Otorhinolaryngol Ital ; 28(2): 89-93, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18669075

RESUMEN

Cervicofacial actinomycosis is the most common clinical form of actinomycosis. This bacterial infection is rare. Diagnosis is difficult, often it is definitive only after surgical excision of the cervicofacial mass. Personal experience is reported concerning two cases of cervicoactinomycosis. Diagnosis, in both cases, has been based on histological findings, not on clinical symptoms. A review of the literature shows that mainly males are affected by this condition and, in fact, both patients described here are males. Symptoms of acute infection were absent. Both patients denied any history of oromaxillofacial trauma or recent dental extraction or oral manipulations. Imaging techniques--ultrasonography and computerized tomography--were not effective in making the diagnosis, in either of these patients. Furthermore, fine needle aspiration cytology did not provide a definitive diagnosis. Both patients underwent surgical excision of the mass. Penicillin was the drug of choice in post-operative long-term treatment (one month). In one of the two men, intravenous steroids were administered. As in several reports in the literature, the definitive diagnosis was histological and not clinical.


Asunto(s)
Actinomicosis Cervicofacial/patología , Actinomicosis Cervicofacial/diagnóstico por imagen , Actinomicosis Cervicofacial/microbiología , Adulto , Humanos , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
8.
Acta Otorhinolaryngol Ital ; 27(5): 255-7, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18198756

RESUMEN

Laryngocele is a rare, benign dilatation of the laryngeal saccule that may extend internally into the airway or externally through the thyrohyoid membrane. Many laryngoceles are asymptomatic; sometimes they may cause a cough, hoarseness, stridor, sore throat and may present as a swelling on one or both sides of the neck. Laryngocele may be associated with supraglottic squamous cell carcinoma. Computed tomography scan is the most effective imaging method for diagnosis. Surgery is the treatment of choice. A case of large mixed laryngocele in a 75-year-old male is described together with surgical management and followup. A review of the literature is also presented.


Asunto(s)
Dilatación Patológica/patología , Laringe/patología , Anciano , Dilatación Patológica/diagnóstico por imagen , Dilatación Patológica/cirugía , Humanos , Laringe/diagnóstico por imagen , Laringe/cirugía , Masculino , Tomografía Computarizada por Rayos X
9.
Acta Otorhinolaryngol Ital ; 26(1): 47-52, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18383758

RESUMEN

Aim of the present investigation was to analyse the possible malignant transformation of oral lichen planus to carcinoma, especially in the atrophic erosive forms and those displaying plaques involving the top of the tongue. A review has been made of the literature, from 1986 to the present day. This search outlines the relationship between oral lichen planus, hepatitis C virus infection, Epstein-Barr virus infection and the importance of periodic follow-up in all patients with oral lichen planus. The case is described of malignant transformation of oral lichen planus to oral cancer in a female presenting asymptomatic hepatitis C virus infection. The clinical history confirms the most important aspects of the relationship between oral lichen planus and oral cancer. Oral lichen planus should be considered as a precancerous lesion, particularly in patients presenting hepatitis C virus infection, requiring follow-up, at close intervals, starting from 3 months after diagnosis.


Asunto(s)
Carcinoma de Células Escamosas/complicaciones , Carcinoma de Células Escamosas/patología , Transformación Celular Neoplásica/patología , Liquen Plano Oral/complicaciones , Liquen Plano Oral/patología , Biopsia , Femenino , Humanos , Persona de Mediana Edad
10.
Appl Radiat Isot ; 103: 143-50, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26093366

RESUMEN

A simple method for measuring (226)Ra in drinking waters has been validated and validation parameters are provided. It is based on the measurement by LSC of (222)Rn, at equilibrium with (226)Ra, which is absorbed into a water immiscible scintillation cocktail (Ultima Gold F) inside the counting vial. The validated application field ranges between the detection limit (2·10(-3) Bq/kg) to 150 Bq/kg. The method has proven to be reliable, effective and suitable for wide-range measuring campaigns. A summary of results obtained in recent years is also given.

11.
J Clin Endocrinol Metab ; 86(2): 675-8, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11158030

RESUMEN

Subclinical Addison's disease is characterized by the presence of adrenal autoantibodies (ACA) and steroid 21-hydroxylase autoantibodies (21OHAb) with or without adrenal function failure. In our previous longitudinal study some patients with high titers of ACA and at stage 2 of subclinical adrenocortical failure showed disappearance of ACA with recovery of normal adrenocortical function after corticosteroid treatment for Graves' ophthalmopathy. To investigate whether corticosteroid-induced modification of the adrenal autoimmune markers can also involve 21OHAb and to evaluate whether the remission of subclinical adrenocortical failure can persist over a long period of time, we followed-up for 100 months the levels of 21OHAb and ACA as well as the metabolic markers of adrenal function in one patient with Graves' ophthalmopathy and at stage 2 of subclinical adrenocortical failure before and after corticosteroid therapy. A 34-yr-old woman with Graves' disease and active ophthalmopathy who was found to be positive for ACA and to have high PRA, low aldosterone levels, and normal basal ACTH and cortisol levels, but impaired cortisol response to ACTH was studied. The patient was treated with oral corticosteroid therapy for 6 months. After corticosteroid therapy, 21OHAb, initially positive, became negative in concomitance with the disappearance of ACA and the restoration of normal adrenal function. The disappearance of both 21OHAb and ACA and their prolonged absence during the follow-up suggest that corticosteroid treatment can induce long-term remission of subclinical adrenal insufficiency and prevent the onset of the clinical phase of the disease. Our pilot study may pave the way to future trials aimed at preventing the onset of the clinical signs of Addison's disease in ACA/21OHAb-positive patients.


Asunto(s)
Enfermedades de la Corteza Suprarrenal/inmunología , Corticoesteroides/efectos adversos , Enfermedades Autoinmunes/inmunología , Enfermedad de Graves/tratamiento farmacológico , Prednisona/efectos adversos , Esteroide 21-Hidroxilasa/inmunología , Enfermedades de la Corteza Suprarrenal/sangre , Enfermedades de la Corteza Suprarrenal/inducido químicamente , Hormona Adrenocorticotrópica/sangre , Adulto , Aldosterona/sangre , Anticuerpos/sangre , Enfermedades Autoinmunes/sangre , Enfermedades Autoinmunes/inducido químicamente , Biomarcadores/sangre , Femenino , Estudios de Seguimiento , Humanos , Hidrocortisona/sangre , Factores de Tiempo
12.
J Clin Endocrinol Metab ; 83(4): 1222-5, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9543145

RESUMEN

It is commonly recognized that a few patients with Graves' disease (GD) develop an overt ophthalmopathy, although most of them show subclinical extraocular muscle enlargement by appropriate imaging techniques. At present, it is not possible to identify the subgroup of GD patients with subclinical retroorbital connective involvement. Recently, it has been shown that increase of soluble intercellular adhesion molecule-1 (sICAM-1) serum levels is correlated to clinical activity score in active Graves' ophthalmopathy (GO) patients with or without hyperthyroidism, suggesting that sICAM-1 serum values could reflect the degree of ocular inflammatory activity. The aim of this longitudinal study was to evaluate sICAM-1 serum levels in GD patients without clinical ophthalmopathy and to assess their possible relationship with occurrence of GO. We measured sICAM-1 serum levels in 103 initially hyperthyroid GD patients without clinical ophthalmopathy and in 100 healthy subjects. All patients were treated with methimazole for 2 yr. Sera were collected from all patients before treatment and then monthly for the first 6 months of therapy, every 2 months in the following 6 months, and finally at the end of the follow-up study. Patients developing GO were excluded from the follow-up at the onset of ophthalmopathy. During the follow-up 17 GD patients (16.5%, group 1) developed overt eye involvement (14 as active inflammatory ophthalmopathy and 3 as ophthalmopathy without clinical retroorbital connective inflammation) and 86 (83.5%, group 2) did not. At start of the study, the mean of sICAM-1 serum concentrations did not differ significantly between the 2 groups, but it was significantly higher than in controls in both groups. No significant correlation between serum sICAM-1 concentrations and free thyroid hormone levels was found in the 2 groups of patients. During the follow-up study, a further increase of sICAM-1 serum levels was observed in 12 of the 14 patients (85.7%) of group 1 who developed active inflammatory ophthalmopathy not only at the onset but also before clinical GO appearance. On the contrary, the 3 patients of group 1 that developed ophthalmopathy without clinical retroorbital inflammation did not show any further increase of sICAM-1 levels at every time of follow-up in comparison with the starting values, even if their sICAM-1 levels were always higher than in normal controls. Finally, group 2 patients showed significantly decreased sICAM-1 levels throughout the follow-up period when compared with the starting values, although they were still significantly higher than in controls. These results indicate that a further increase of sICAM-1 serum levels before the onset of clinical ophthalmopathy may be a marker of subclinical retroorbital connective inflammation in GD patients. Therefore, our study suggests that serial determinations of sICAM-1 serum levels could help to identify and trace at the right time those GD patients prone to developing active inflammatory ophthalmopathy.


Asunto(s)
Oftalmopatías/sangre , Enfermedad de Graves/sangre , Molécula 1 de Adhesión Intercelular/sangre , Adulto , Antitiroideos/uso terapéutico , Oftalmopatías/diagnóstico , Femenino , Estudios de Seguimiento , Enfermedad de Graves/tratamiento farmacológico , Humanos , Masculino , Metimazol/uso terapéutico , Persona de Mediana Edad , Solubilidad
13.
Opt Express ; 2(12): 483-90, 1998 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-19381219

RESUMEN

We report on experiments dealing with the propagation of a collimated laser beam in a dye doped nematic confined in a capillary of optical fiber size. The nematic is aligned in a such a way that the source beam is self focused. The behavior of the beam - focusing, multifocus regime, filamentation and undulation - already observed in larger cylindrical geometry and pure nematic is shown here to be reproduced in the dye doped medium, at much lower powers. Another feature is reported here: a stable regime looking like a waveguide appears in certain conditions, in which the beam to propagate in a narrow tube. This regime is simply modeled in terms of saturated reorientation of the nematic.

14.
Brain Res ; 529(1-2): 85-90, 1990 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-1980848

RESUMEN

Methylenedioxymethamphetamine (MDMA) produced a significant hyperthermia in rats which was antagonized in a competitive manner by the selective 5-HT2 antagonist, MDL 11,939. The 5-HT antagonist also blocked MDMA-induced neurotoxicity as assessed by the decline in regional 5-HT concentrations observed 1 week later. These two effects of MDL 11,939 were dissociated at higher doses of MDMA where the antagonist still provided virtually complete protection against the neurochemical deficits but only partially attenuated the hyperthermic response. In contrast to the effect of the 5-HT2 antagonist, haloperidol did not alter MDMA-induced hyperthermia but did antagonize its long-term neurochemical effects. Similarly, coadministration of the selective 5-HT uptake inhibitor, MDL 27,777, did not affect the hyperthermia produced by a high dose of MDMA but completely prevented the depletion of 5-HT. When the MDMA-induced hyperthermia was prevented by temporarily maintaining animals at reduced ambient temperature, the neurochemical changes normally observed 1 week later were also blocked. Although these results demonstrate that the drugs tested do not antagonize MDMA-induced neurotoxicity by interfering with its effect on body temperature, they do indicate that MDMA-induced hyperthermia may contribute to the development of the drug's long-term neurochemical effects.


Asunto(s)
3,4-Metilenodioxianfetamina/análogos & derivados , Temperatura Corporal/efectos de los fármacos , Corteza Cerebral/metabolismo , Cuerpo Estriado/metabolismo , Hipocampo/metabolismo , Neurotoxinas/farmacología , Receptores de Serotonina/fisiología , Serotonina/metabolismo , 3,4-Metilenodioxianfetamina/farmacología , Animales , Corteza Cerebral/efectos de los fármacos , Cuerpo Estriado/efectos de los fármacos , Haloperidol/farmacología , Hipocampo/efectos de los fármacos , Masculino , N-Metil-3,4-metilenodioxianfetamina , Piperidinas/farmacología , Ratas , Ratas Endogámicas , Receptores de Serotonina/efectos de los fármacos , Valores de Referencia , Antagonistas de la Serotonina/farmacología
15.
Eur J Pharmacol ; 191(2): 213-6, 1990 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-1982264

RESUMEN

We report that maintaining rats under chloral hydrate anesthesia for the first 3 h following the administration of 3,4-methylenedioxymethamphetamine (MDMA) blocks the decrease in forebrain concentrations of 5-hydroxytryptamine (5-HT) measured 1 week later. In contrast, the acute effect of MDMA (3 h) on forebrain 5-HT was not altered by the anesthetic. This protective effect of chloral hydrate was not due to an anesthetic-induced hypothermia but may be related to the hypothesized role of dopamine in the neurotoxic effects of MDMA.


Asunto(s)
3,4-Metilenodioxianfetamina/análogos & derivados , Anestesia , Corteza Cerebral/efectos de los fármacos , Hidrato de Cloral/farmacología , Hipocampo/efectos de los fármacos , Serotonina/metabolismo , 3,4-Metilenodioxianfetamina/antagonistas & inhibidores , 3,4-Metilenodioxianfetamina/toxicidad , Animales , Corteza Cerebral/citología , Corteza Cerebral/metabolismo , Hipocampo/citología , Hipocampo/metabolismo , Masculino , N-Metil-3,4-metilenodioxianfetamina , Premedicación , Ratas , Ratas Endogámicas
16.
Oncol Rep ; 6(6): 1357-62, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10523712

RESUMEN

Patients receiving systemic cancer chemotherapy must often have their dose intensity of therapeutic agents reduced, because a broad range of organs are adversely affected. Therefore, research and the development of agents protecting the normal tissues from the toxicity of antineoplastic therapy, without reducing the antitumour efficacy, are very important. Amifostine, a prodrug that forms an activated free thiol, when dephosphorylated by alkaline phosphatase, appears selective in its entry in non-malignant cells, and exerts a protective effect from toxicity induced by chemo- or radiotherapy on normal tissues, through free radical scavenging, hydrogen donation and inhibition of DNA damage. Studies in vitro and experimental models have confirmed the protective properties of amifostine in normal cells. In clinical trials pretreatment with amifostine reduced the frequency of cyclophosphamide induced neutropenia and nephro-, oto- and neurotoxicity of platinum compounds. In some cases the use of amifostine have also potentiated the effects of several drugs, such as alkylating agents and, in recent studies, taxanes. The main potentially dose-limiting adverse effect is hypotension, that is often asymptomatic. Amifostine is thus usefully employed in order to obtain a better quality of life in patients receiving oncologic treatments.


Asunto(s)
Amifostina/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias/tratamiento farmacológico , Neoplasias/radioterapia , Protectores contra Radiación/farmacología , Radioterapia/efectos adversos , Amifostina/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Humanos , Protectores contra Radiación/uso terapéutico
17.
Oncol Rep ; 7(2): 397-400, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10671693

RESUMEN

The aim of this study was to assess the protective effect and the safety profile of amifostine in 16 esophageal cancer patients undergoing neoadjuvant chemo-radiation therapy (group A) compared to 21 matched patients (group B), treated with the same schedule without receiving amifostine, and considered as controls. Haematological and extra-haematological toxicity were evaluated according to WHO criteria and considered as result of amifostine activity. The bone marrow toxicity was globally lower in group A than in group B. We recorded 4 cases of mucosities in group B compared to 1 case in group A. amifostine-related side effects were few (2 cases of hypotension and 1 of vomiting), mild, and well controlled. In conclusion, amifostine seems to be effective and safe when used as protective agent also in esophageal cancer.


Asunto(s)
Amifostina/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias Esofágicas/tratamiento farmacológico , Terapia Neoadyuvante , Protectores contra Radiación/administración & dosificación , Anciano , Amifostina/efectos adversos , Cisplatino/administración & dosificación , Terapia Combinada , Neoplasias Esofágicas/fisiopatología , Neoplasias Esofágicas/radioterapia , Neoplasias Esofágicas/cirugía , Femenino , Fluorouracilo/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Protectores contra Radiación/efectos adversos
18.
Pathol Res Pract ; 197(6): 449-52, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11432673

RESUMEN

Primary adenocarcinoma of the larynx is a rare neoplasm that tends to spread to both regional lymph nodes and distant sites. A case of primary adenocarcinoma of the arytenoid in a 74-year-old man is presented. The tumor was evaluated by light and electron microscopy. A high percentage of intranuclear pseudoinclusions (more than 20% of the neoplastic cells) was a peculiar characteristic of the tumor. To the best of our knowledge, such a feature has not been reported previously and should be considered a hallmark of more aggressive behavior.


Asunto(s)
Adenocarcinoma/ultraestructura , Cartílago Aritenoides/ultraestructura , Neoplasias Laríngeas/ultraestructura , Adenocarcinoma/radioterapia , Anciano , Núcleo Celular/ultraestructura , Humanos , Cuerpos de Inclusión/ultraestructura , Neoplasias Laríngeas/radioterapia , Laringoscopía , Imagen por Resonancia Magnética , Masculino , Cuidados Paliativos
19.
Clin Rheumatol ; 20(1): 53-6, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11254242

RESUMEN

A bilateral knee septic arthritis due to Salmonella enteritidis developed in a female patient affected by long-standing systemic lupus erythematosus (SLE) with cardiac and renal involvement treated with immunosuppressants and corticosteroids. Because avascular necrosis and multiple osteomyelitic areas were detected at the same time in both right and left femoral condyles, an early localisation of Salmonella into the bone was assumed. Involvement of the joints was regarded as consequence of local dissemination of infection. Ampicilline (0.2 g/kg body weight daily for 2 months) plus ciprofloxacin (1.5 g daily for 12 months) and withdrawal of immunosuppressants appeared to be effective in preventing complications of infection.


Asunto(s)
Artritis Infecciosa/etiología , Articulación de la Rodilla , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/patología , Osteomielitis/etiología , Infecciones por Salmonella , Salmonella enteritidis , Adulto , Femenino , Humanos
20.
Drugs Exp Clin Res ; 11(1): 39-48, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3869802

RESUMEN

The in vitro antimicrobial activity of imipenem against recent clinical isolates of Pseudomonas spp. (94 strains) and penicillin-resistant Staphylococcus spp. (50 Staph. aureus and 50 coagulase-negative Staphylococcus) was assessed using the Mueller-Hinton agar dilution method. Results were compared with those simultaneously obtained for amikacin, netilmicin, tobramycin, norfloxacin, piperacillin, ceftazidime, ceftriaxone and azthreonam against Pseudomonas spp., and for rifampicin, clindamycin, netilmicin and cefoxitin, besides penicillin and methacillin, against Staphylococcus spp. About 50 and 90% of 84 Pseudomonas aeruginosa isolates were inhibited by concentrations of imipenem equal to or less than 2 and 8 mg/l respectively. The in vitro activity of imipenem was comparable to that of ceftazidime and norfloxacin, but superior to that of the aminoglycosides and all the other antibiotics tested, in terms of potency by weight. Among other Pseudomonas spp. only P. malthophilia (2 strains) proved resistant to imipenem. Rifampicin was the most active antibiotic by weight against Staph. aureus but imipenem was more active than clindamycin and, especially, netilmicin and cefoxitin. Imipenem was highly active also against coagulase-negative staphylococci, with some differences related to the high incidence of methicillin-resistant strains. MICs of imipenem in Mueller-Hinton broth correlated with those obtained in agar, unlike the aminoglycosides. There were no significant inoculum effects on MICs of imipenem and MBCs were within one twofold dilution of MICs in over 75% of assays.


Asunto(s)
Antibacterianos/farmacología , Staphylococcus aureus/efectos de los fármacos , Tienamicinas/farmacología , Aminoglicósidos/farmacología , Cefalosporinas/farmacología , Farmacorresistencia Microbiana , Imipenem , Pruebas de Sensibilidad Microbiana , Pseudomonas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA